These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32448971)

  • 1. National trends in the use of PSA, urinalysis, and digital rectal exam for evaluation of lower urinary tract symptoms in men.
    Doolin J; Reese ZA; Mukamal KJ
    World J Urol; 2021 Mar; 39(3):855-860. PubMed ID: 32448971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Welliver C; Feinstein L; Ward JB; Kirkali Z; Martinez-Miller EE; Matlaga BR; McVary K
    Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):269-273. PubMed ID: 34545201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.
    Carballido J; Fourcade R; Pagliarulo A; Brenes F; Boye A; Sessa A; Gilson M; Castro R
    Int J Clin Pract; 2011 Sep; 65(9):989-96. PubMed ID: 21733048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSA predicts development of incident lower urinary tract symptoms: results from the REDUCE study.
    Patel DN; Feng T; Simon RM; Howard LE; Vidal AC; Moreira DM; Castro-Santamaria R; Roehrborn C; Andriole GL; Freedland SJ
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):238-244. PubMed ID: 29795141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Indian/Alaska Native men are less likely to receive prostate-specific antigen testing and digital rectal exams from primary care providers than White men: a secondary analysis of the National Ambulatory Medical Care Survey from 2012-2018.
    Gillette C; Locklear T; Bell R; Bates N; Ostermann J; Reuland D; Foley K; Lashmit C; Crandall S
    Cancer Causes Control; 2023 Sep; 34(9):749-756. PubMed ID: 37217700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Sutcliffe S; Grubb Iii RL; Platz EA; Ragard LR; Riley TL; Kazin SS; Hayes RB; Hsing AW; Andriole GL;
    BJU Int; 2012 Oct; 110(7):1050-9. PubMed ID: 22429766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
    Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
    J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management.
    Lerner LB; McVary KT; Barry MJ; Bixler BR; Dahm P; Das AK; Gandhi MC; Kaplan SA; Kohler TS; Martin L; Parsons JK; Roehrborn CG; Stoffel JT; Welliver C; Wilt TJ
    J Urol; 2021 Oct; 206(4):806-817. PubMed ID: 34384237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men.
    Stone BV; Shoag J; Halpern JA; Mittal S; Lewicki P; Golombos DM; Bedretdinova D; Chughtai B; Barbieri CE; Lee RK
    BJU Int; 2017 Feb; 119(2):298-304. PubMed ID: 27480499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benign prostatic hyperplasia: clinical manifestations and evaluation.
    Santos Dias J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of lower urinary tract symptoms and prostate enlargement in the primary care setting.
    Naslund MJ; Gilsenan AW; Midkiff KD; Bown A; Wolford ET; Wang J
    Int J Clin Pract; 2007 Sep; 61(9):1437-45. PubMed ID: 17686091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Do urologists apply benign prostatic hyperplasia clinical practice guidelines? Survey on the complementary investigation request modalities in France].
    de la Taille A; Desgrandchamps F; Saussine C; Lukacs B; Haillot O
    Prog Urol; 2004 Jun; 14(3):320-5. PubMed ID: 15373173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of tools for objective evaluation of infravesical obstruction of men with lower urinary tract symptoms.
    Mazzariol O; Reis LO; Palma PR
    Int Braz J Urol; 2019; 45(4):775-781. PubMed ID: 31136110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of BPH and lower urinary tract symptoms in West Africans.
    Chokkalingam AP; Yeboah ED; Demarzo A; Netto G; Yu K; Biritwum RB; Tettey Y; Adjei A; Jadallah S; Li Y; Chu LW; Chia D; Niwa S; Partin A; Thompson IM; Roehrborn C; Hoover RN; Hsing AW
    Prostate Cancer Prostatic Dis; 2012 Jun; 15(2):170-6. PubMed ID: 21912428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based guidelines for the management of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary.
    Spatafora S; Conti G; Perachino M; Casarico A; Mazzi G; Pappagallo GL;
    Curr Med Res Opin; 2007 Jul; 23(7):1715-32. PubMed ID: 17588302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Work-Up of Lower Urinary Tract Symptoms.
    Hecht SL; Hedges JC
    Urol Clin North Am; 2016 Aug; 43(3):299-309. PubMed ID: 27476123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sexually transmitted infections, benign prostatic hyperplasia and lower urinary tract symptom-related outcomes: results from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Breyer BN; Huang WY; Rabkin CS; Alderete JF; Pakpahan R; Beason TS; Kenfield SA; Mabie J; Ragard L; Wolin KY; Grubb RL; Andriole GL; Sutcliffe S
    BJU Int; 2016 Jan; 117(1):145-54. PubMed ID: 25601300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.